NKGen Biotech, Inc. Warrants

NKGen Biotech, Inc. Warrants

NKGNW
NKGen Biotech, Inc. WarrantsUS flagNASDAQ Global Market
0.03
USD
+0.03
- -
6.18MMarket Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
As of date
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- Cost of Revenue
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
Gross Profit
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- Operating Expenses
22
24
30
+ Selling, General & Admin
8
8
14
+ Research & Development
15
17
16
+ Other Operating Expense
- -
- -
- -
Operating Income (Loss)
-22
-24
-30
- Non-Operating (Income) Loss
1
2
53
+ Interest Expense, Net
1
2
1
+ Interest Expense
1
2
1
- Interest Income
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
52
Pretax Income
-23
-27
-83
- Income Tax Expense (Benefit)
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
Income (Loss) from Cont Ops
-23
-27
-83
- Net Extraordinary Losses (Gains)
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
Income (Loss) Incl. MI
-23
-27
-83
- Minority Interest
- -
- -
- -
Net Income, GAAP
-23
-27
-83
- Preferred Dividends
- -
- -
- -
- Other Adjustments
- -
- -
- -
Net Income Avail to Common, GAAP
-23
-27
-83
EBIT
-22
-24
-30
EBITDA
-21
-23
-29
EBITDA Margin (%)
-4,839.67
-30,046.75
- -
EBITA
-22
-24
-30
Gross Margin (%)
92.96
76.62
- -
Operating Margin (%)
-5,131.69
-31,618.18
- -
Profit Margin (%)
-5,461.27
-34,745.45
- -
Sales per Employee
- -
- -
- -
Dividend per Share
- -
- -
- -
Depreciation Expense
1
1
1
Basic Weighted Avg Shares
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
Basic EPS from Cont Ops
- -
- -
- -
Diluted Weighted Avg Shares
- -
- -
- -
Diluted EPS, GAAP
- -
- -
- -
Diluted EPS from Cont Ops
- -
- -
- -

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
As of date
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
1
- -
2
+ Cash, Cash Equivalents & STI
- -
- -
- -
+ Cash & Cash Equivalents
- -
- -
- -
+ ST Investments
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
+ Inventories
- -
- -
- -
+ Raw Materials
- -
- -
- -
+ Work In Process
- -
- -
- -
+ Finished Goods
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
+ Other Inventory
- -
- -
- -
+ Other ST Assets
- -
- -
2
+ Misc ST Assets
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
Total Noncurrent Assets
17
16
15
+ Property, Plant & Equip, Net
17
16
14
+ Property, Plant & Equip
19
19
18
- Accumulated Depreciation
2
3
4
+ LT Investments & Receivables
- -
- -
- -
+ LT Investments
- -
- -
- -
+ LT Receivables
- -
- -
- -
+ Other LT Assets
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
+ Goodwill
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
Total Assets
18
16
16
+ Payables & Accruals
4
2
13
+ Accounts Payable
2
1
11
+ Accrued Taxes
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
+ Other Payables & Accruals
2
1
2
+ ST Debt
52
12
10
+ ST Borrowings
51
12
10
+ ST Finance Leases
- -
- -
- -
+ Other ST Liabilities
- -
- -
17
+ Deferred Revenue
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
+ Misc ST Liabilities
- -
- -
17
Total Current Liabilities
56
15
39
+ LT Debt
- -
- -
10
+ LT Borrowings
- -
- -
10
+ LT Finance Leases
- -
- -
- -
+ Other LT Liabilities
- -
- -
26
+ Accrued Liabilities
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
+ Misc LT Liabilities
- -
- -
26
Total Noncurrent Liabilities
- -
- -
36
Total Liabilities
56
15
75
+ Preferred Equity and Hybrid Capital
- -
- -
- -
+ Share Capital & APIC
14
81
122
+ Common Stock
- -
- -
- -
+ Additional Paid in Capital
14
81
122
- Treasury Stock
- -
- -
- -
+ Retained Earnings
-52
-79
-162
+ Other Equity
- -
- -
- -
Equity Before Minority Interest
-38
2
-59
+ Minority/Non Controlling Interest
- -
- -
- -
Total Equity
-38
2
-59
Total Liabilities & Equity
18
16
16
Shares Outstanding
22
22
22
Number of Employees
- -
- -
- -
Capital Leases - Total
1
- -
- -
Net Debt
51
12
20
Net Debt to Equity
-133.51
738.2
-33.9
Tangible Common Equity Ratio
-212.12
9.03
-358.69
Current Ratio
0.01
0.02
0.05
Cash Conversion Cycle
- -
-27,194.74
- -

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
As of date
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-23
-27
-83
+ Depreciation & Amortization
1
1
1
+ Non-Cash Items
2
3
58
+ Stock-Based Compensation
- -
- -
4
+ Deferred Income Taxes
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
+ Other Non-Cash Adj
1
3
53
+ Chg in Non-Cash Work Cap
1
- -
2
+ (Inc) Dec in Accts Receiv
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
+ Inc (Dec) in Accts Payable
1
- -
4
+ Inc (Dec) in Other
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Operating Activities
-20
-23
-22
+ Change in Fixed & Intang
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
2
+ Increase in Capital Stock
- -
- -
2
+ Decrease in Capital Stock
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
+ Cash for JVs
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
+ Dividends Paid
- -
- -
- -
+ Net Cash From Debt
20
22
26
+ Cash From Debt
20
23
27
+ Repayments of Debt
-1
-1
- -
+ Other Financing Activities
- -
- -
-6
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Financing Activities
20
22
22
Effect of Foreign Exchange Rates
- -
- -
- -
Net Changes in Cash
- -
- -
- -
EBITDA
-21
-23
-29
EBITDA Margin (%)
-4,839.67
-30,046.75
- -
Free Cash Flow
-20
-23
-22
Net Cash Paid for Acquisitions
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
Free Cash Flow to Equity
- -
- -
4
Free Cash Flow per Basic Share
- -
- -
- -
Price/Free Cash Flow
- -
- -
- -
Cash Flow to Net Income
0.84
0.84
0.26
Capital Expenditures
- -
- -
- -